Amicus Therapeutics, Inc. revenue breakdown overview

Amicus Therapeutics, Inc. revenue for the last year amounted to 528.29 M USD, the most of which — 528.29 M USD — came from its highest performing source at the moment, Advanced Therapies, the year earlier bringing 399.36 M USD. The greatest contribution to the revenue figure was made by Non-United States — last year it brought Amicus Therapeutics, Inc. 322.15 M USD, and the year before that — 252.42 M USD.